Fate Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Fate Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Fate Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Fate Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Fate Therapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Fate Therapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
William Rastetter, Ph.D.
Chairman Executive BoardDr. William H. Rastetter has been the Chairman of the company since 2011. Prior to that, he served as interim Chief Executive Officer from February 2012 to October 2012. Previously he served as a Director and Chairman of the Board at Receptos Inc from 2009 to 2015. He served as an acting Chief Executive Officer, Chairman and Director at Illumina Inc. He served as the Executive Chairman at Biogen Idec from 2003 to 2005.
Bahram Valamehr, Ph.D.
Chief Executive Officer; President Senior ManagementMr Valamehr has been the President, Director and Chief Executive Officer of the company since January 2025. Prior to this, he served as the President of Research and Development of the company. Previously, he served as the Chief Development Officer of the company. He served as the Vice President of Cancer Immunotherapy of the company from 2016 to 2018. He also served in various scientific roles at Amgen and the Broad Stem Cell Research Center.
Kamal Adawi
Treasurer; Chief Financial Officer Senior ManagementMr. Kamal Adawi has been the Chief Financial Officer of the company since October 2025. Prior to this, he served as the Chief Financial Officer at Mindera Health. Previously, he served as the Corporate Secretary at Exagen Inc. He also served as the Chief Financial Officer at Pathway Genomics. He held various financial leadership positions at Becton Dickinson, GenMark Dx and Digirad Corporation.
Cindy R. Tahl
Chief Legal & Compliance Officer Senior ManagementMs. Cindy R. Tahl is the Chief Legal & Compliance Officer of the company. Prior to this, she served as the Vice President, IP and Senior Corporate Counsel of the company from December 2013 to October 2015. Previously, he served as the Senior Director, Intellectual Property and Corporate Counsel from 2009 to 2013. He served as the technology transactions attorney at the law firm of Wilson Sonsini Goodrich and Rosati, P.C from 2007 to 2009.
Noreen Blanchett
Deputy General Counsel; Vice President Senior ManagementStill looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer